BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 38448852)

  • 21. The added value of chest imaging after neoadjuvant radiotherapy for soft tissue sarcoma of the extremities and trunk wall: A retrospective cohort study.
    Acem I; Schultze BTA; Schoonbeek A; van Houdt WJ; van de Sande MAJ; Visser JJ; Grünhagen DJ; Verhoef C
    Eur J Surg Oncol; 2022 Jul; 48(7):1543-1549. PubMed ID: 35393169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment-induced pathologic necrosis: a predictor of local recurrence and survival in patients receiving neoadjuvant therapy for high-grade extremity soft tissue sarcomas.
    Eilber FC; Rosen G; Eckardt J; Forscher C; Nelson SD; Selch M; Dorey F; Eilber FR
    J Clin Oncol; 2001 Jul; 19(13):3203-9. PubMed ID: 11432887
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of perioperative chemotherapy and radiotherapy in patients with primary extremity soft tissue sarcoma: retrospective analysis across major histological subtypes and major reference centres.
    Callegaro D; Miceli R; Bonvalot S; Ferguson P; Strauss DC; Levy A; Griffin A; Hayes AJ; Stacchiotti S; Le Pèchoux C; Smith MJ; Fiore M; Dei Tos AP; Smith HG; Catton C; Casali PG; Wunder JS; Gronchi A
    Eur J Cancer; 2018 Dec; 105():19-27. PubMed ID: 30384013
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A phase II study evaluating neo-/adjuvant EIA chemotherapy, surgical resection and radiotherapy in high-risk soft tissue sarcoma.
    Schmitt T; Lehner B; Kasper B; Bischof M; Roeder F; Dietrich S; Dimitrakopoulou-Strauss A; Strauss LG; Mechtersheimer G; Wuchter P; Ho AD; Egerer G
    BMC Cancer; 2011 Dec; 11():510. PubMed ID: 22152120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Limb salvage by neoadjuvant isolated perfusion with TNFalpha and melphalan for non-resectable soft tissue sarcoma of the extremities.
    Lejeune FJ; Pujol N; Liénard D; Mosimann F; Raffoul W; Genton A; Guillou L; Landry M; Chassot PG; Chiolero R; Bischof-Delaloye A; Leyvraz S; Mirimanoff RO; Bejkos D; Leyvraz PF
    Eur J Surg Oncol; 2000 Nov; 26(7):669-78. PubMed ID: 11078614
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic impact of the post-treatment T cell composition and spatial organization in soft tissue sarcoma patients treated with neoadjuvant hyperthermic radio(chemo)therapy.
    Rupp L; Resag A; Potkrajcic V; Warm V; Wehner R; Jöhrens K; Bösmüller H; Eckert F; Schmitz M
    Front Immunol; 2023; 14():1185197. PubMed ID: 37261361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unplanned Resections of Soft Tissue Sarcomas-Necessity of Re-Resection?
    Fromm J; Klein A; Mentrup F; Lindner LH; Nachbichler S; Holzapfel BM; Goller SS; Knösel T; Dürr HR
    Cancers (Basel); 2024 May; 16(10):. PubMed ID: 38791930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neoadjuvant treatment improves capsular integrity and the width of the fibrous capsule of high-grade soft-tissue sarcomas.
    Grabellus F; Podleska LE; Sheu SY; Bauer S; Pöttgen C; Kloeters C; Hoiczyk M; Lauenstein TC; Schmid KW; Taeger G
    Eur J Surg Oncol; 2013 Jan; 39(1):61-7. PubMed ID: 23103117
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How Are Indeterminate Pulmonary Nodules at Diagnosis Associated with Survival in Patients with High-Grade Osteosarcoma?
    Tsoi KM; Lowe M; Tsuda Y; Lex JR; Fujiwara T; Almeer G; Gregory J; Stevenson J; Evans SE; Botchu R; Jeys LM
    Clin Orthop Relat Res; 2021 Feb; 479(2):298-308. PubMed ID: 32956141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor necrosis has no prognostic value in neoadjuvant chemotherapy for soft tissue sarcoma.
    Menendez LR; Ahlmann ER; Savage K; Cluck M; Fedenko AN
    Clin Orthop Relat Res; 2007 Feb; 455():219-24. PubMed ID: 17016226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The complexity of management of pregnancy-associated malignant soft tissue and bone tumors.
    Molho RB; Kollender Y; Issakov J; Bickels J; Flusser G; Azem F; Alon A; Inbar MJ; Meller I; Merimsky O
    Gynecol Obstet Invest; 2008; 65(2):89-95. PubMed ID: 17878735
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluating the Role of Interdigitated Neoadjuvant Chemotherapy and Radiation in the Management of High-Grade Soft-Tissue Sarcoma: The Johns Hopkins Experience.
    Raval RR; Frassica D; Thornton K; Meyer C; Ettinger DS; Frassica F; Weber K; Terezakis SA
    Am J Clin Oncol; 2017 Apr; 40(2):214-217. PubMed ID: 25268069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of radiation therapy in the treatment of adult soft tissue sarcomas of the extremities: a long-term community-based cancer center experience.
    Kneisl JS; Ferguson C; Robinson M; Crimaldi A; Ahrens W; Symanowski J; Bates M; Ersek JL; Livingston M; Patt J; Kim ES
    Cancer Med; 2017 Mar; 6(3):516-525. PubMed ID: 28188703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of (18)F-FDG PET at diagnosis in patients with soft tissue sarcoma and bone sarcoma; systematic review and meta-analysis.
    Kubo T; Furuta T; Johan MP; Ochi M
    Eur J Cancer; 2016 May; 58():104-11. PubMed ID: 26990930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of bone and soft-tissue sarcomas registered during the year 2012 at Tata Memorial Hospital, Mumbai, with clinical outcomes.
    Bajpai J; Khanna N; Vora T; Gulia A; Laskar S; Puri A; Sanduptla B; Chinnaswamy G; Nayak P; Juvekar SL; Janu A; Desai S; Ghosh J; Purandare N; Ramadwar M; Rangarajan V; Rekhi B
    Indian J Cancer; 2018; 55(1):37-44. PubMed ID: 30147091
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiotherapy for soft tissue sarcomas after isolated limb perfusion and surgical resection: essential for local control in all patients?
    Deroose JP; Burger JW; van Geel AN; den Bakker MA; de Jong JS; Eggermont AM; Verhoef C
    Ann Surg Oncol; 2011 Feb; 18(2):321-7. PubMed ID: 21049306
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current trials and new aspects in soft tissue sarcoma of adults.
    Issels RD; Schlemmer M
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S4-8. PubMed ID: 12042982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-Term Follow-Up of Patients Receiving Neoadjuvant Treatment Modalties for Soft Tissue Sarcomas of the Extremities.
    Rauch M; Agaimy A; Semrau S; Willner A; Ott O; Fietkau R; Hohenberger W; Croner RS; Grützmann R; Fechner K; Vassos N
    Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Individualised risk assessment for local recurrence and distant metastases in a retrospective transatlantic cohort of 687 patients with high-grade soft tissue sarcomas of the extremities: a multistate model.
    Willeumier JJ; Rueten-Budde AJ; Jeys LM; Laitinen M; Pollock R; Aston W; Dijkstra PD; Ferguson PC; Griffin AM; Wunder JS; Fiocco M; van de Sande MA
    BMJ Open; 2017 Feb; 7(2):e012930. PubMed ID: 28196946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neoadjuvant Chemotherapy Followed by Delayed Surgery: Is it Necessary for All Patients With Nonmetastatic High-Grade Pelvic Osteosarcoma?
    Xu J; Xie L; Guo W
    Clin Orthop Relat Res; 2018 Nov; 476(11):2177-2186. PubMed ID: 29912746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.